Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 4NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Uterine Cervical Neoplasms 4Papillomavirus Infections 4

Interventions

Specimen Handling 6Colposcopy 5Human Papillomavirus DNA Tests 4fludarabine phosphate 2fludarabine 2aldesleukin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Cyclophosphamide 2polyphenon E 1human papillomavirus vaccine, L1 type 16, 18 1adacel 1Vaginal Smears 1Tetanus Toxoid 1Respiratory Function Tests 1Radiotherapy 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Ipilimumab 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Granisetron 1Electrocardiography 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Papillomavirus Infections × Human Papillomavirus DNA Tests × Clear all
NCT06498661 2026-05-13

SHIP-A-S01

National Cancer Institute (NCI)

Phase NA Active not recruiting
750 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281430 2026-05-13

LMI-001-A-S04

National Cancer Institute (NCI)

Phase NA Recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡